Project:Pharmacology working group
Working group·shortcut PP:PHARM
PP:PHARM.Coordinating the compound, receptor and mechanism articles.
The pharmacology working group coordinates work on compound articles, receptor pharmacology and mechanism of action. It maintains the compound infobox conventions and the class articles that the individual compounds hang off.
Scope
Compound articles; receptor and signalling articles; pharmacokinetic concepts; drug nomenclature. Trial articles belong to the clinical evidence group and analytical articles to the analytical group, though the boundaries are soft and nobody polices them.
Current priorities
- Bring the older agonists to the sourcing standard of the newer ones — the pre-2015 compounds are visibly thinner.
- Ensure every compound article states approval status in its lead.
- Standardise how receptor potency values are reported, including the assay they came from. A potency figure without its assay is not comparable to another.
- Review every molar mass and molecular formula against a primary source. Several transcription errors have been found; more probably remain.
Conventions maintained here
Compound infobox row order; the residue-numbering convention for peptide hormones (proglucagon-relative for GLP-1, as settled on Talk:Glucagon-like peptide-1); the treatment of investigational compounds, which are described as investigational in the lead and never in the past tense.